How to buy Hims & Hers Health stock (Hims)

Hims & Hers Health is a household & personal products business based in the US. Hims & Hers Health shares (HIMS) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $26.20 – a decrease of 12.72% over the previous week. Hims & Hers Health employs 1,046 staff and has a trailing 12-month revenue of around $1.2 billion.

Our top picks for where to buy Hims Hers Health stock

Buy Hims & Hers Health stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Hims & Hers Health stock price (NYSE: HIMS)

Use our graph to track the performance of HIMS stocks over time.

Hims & Hers Health shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$26.20
52-week range	$8.09 - $35.02
50-day moving average more info button	$25.04
200-day moving average more info button	$19.06
Wall St. target price	$24.90
PE ratio more info button	64.8864
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.44

Is it a good time to buy Hims & Hers Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Hims & Hers Health price performance over time

Historical closes compared with the close of $26.36 from 2024-12-19

1 week (2024-12-13)	-12.19%
1 month (2024-11-21)	9.15%
3 months (2024-09-20)	61.72%
6 months (2024-06-20)	17.73%

1 year (2023-12-20)	216.07%
2 years (2022-12-20)	296.39%
3 years (2021-12-20)	325.85%
5 years (2019-12-20)	166.40%

Is Hims & Hers Health stock undervalued or overvalued?

Valuing Hims & Hers Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hims & Hers Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Hims & Hers Health's P/E ratio

Hims & Hers Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 65x. In other words, Hims & Hers Health shares trade at around 65x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Hims & Hers Health's P/E ratio is best considered in relation to those of others within the household & personal products industry or those of similar companies.

• Teladoc (TDOC.US): 0.00
• American Well Corp (AMWL.US): 0.00
• Humana (HUM.US): 20.93

Hims & Hers Health's EBITDA

Hims & Hers Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $59.7 million.

The EBITDA is a measure of a Hims & Hers Health's overall financial performance and is widely used to measure a its profitability.

To put Hims & Hers Health's EBITDA into context you can compare it against that of similar companies.

• Teladoc (TDOC.US): USD$66.2 million
• American Well Corp (AMWL.US): USD$-200511008
• Humana (HUM.US): USD$3.8 billion

Hims & Hers Health financials

Revenue TTM	$1.2 billion
Operating margin TTM	5.57%
Gross profit TTM	$408.7 million
Return on assets TTM	5.66%
Return on equity TTM	26.35%
Profit margin	8.15%
Book value	$2.02
Market Capitalization more info button	$6.2 billion

TTM: trailing 12 months

Hims & Hers Health share dividends

We're not expecting Hims & Hers Health to pay a dividend over the next 12 months.

You may also wish to consider:

• Humana (HUM.US) (1.48% forward annual dividend yield)

Hims & Hers Health share price volatility

Over the last 12 months, Hims & Hers Health's shares have ranged in value from as little as $8.09 up to $35.02. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Hims & Hers Health's is 1.062. This would suggest that Hims & Hers Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Hims & Hers Health's beta into context you can compare it against those of similar companies.

• Teladoc (TDOC.US): 0.91
• American Well Corp (AMWL.US): 1.048
• Humana (HUM.US): 0.52

Hims & Hers Health overview

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc.

Frequently asked questions

null
What percentage of Hims & Hers Health is owned by insiders or institutions?
Currently 11.374% of Hims & Hers Health shares are held by insiders and 65.34% by institutions. How many people work for Hims & Hers Health?
Latest data suggests 1,046 work at Hims & Hers Health. When does the fiscal year end for Hims & Hers Health?
Hims & Hers Health's fiscal year ends in December. Where is Hims & Hers Health based?
Hims & Hers Health's address is: 2269 Chestnut Street, San Francisco, CA, United States, 94123 What is Hims & Hers Health's ISIN number?
Hims & Hers Health's international securities identification number is: US4330001060